OncoK9 – Early Cancer Detection For Dogs

OncoK9 is a first-in-class multi-cancer early detection (MCED) test. It utilizes the same cutting-edge genomic sequencing technology that has revolutionized early cancer detection in human patients.

Cancer is by far the single most common cause of death in adult dogs—approximately six million are diagnosed with the disease annually in the United States. Unfortunately, it is typically diagnosed in an advanced stage, when treatment options are limited. All too often, it cuts short the lives of dogs who might have enjoyed many healthy years with their families had the disease been found sooner. Early detection provides the greatest chance of a successful outcome.

OncoK9 can detect 30 different cancer types, including eight of the most common cancers in dogs. It is recommended as an annual screening test for all dogs starting at 7 years of age and potentially at younger ages for dogs belonging to breeds that are predisposed to cancer.

We are proud to announce that we have partnered with PetDx, the lab which performs the test, to provide up to $1,000.00 in follow-up diagnostics at no charge to the pet parent of any dog who receives a positive result from the screening test.

As with any laboratory test, OncoK9 results should be interpreted by a veterinarian in the context of each patient’s medical history and clinical presentation. The test is available by prescription only.

To participate in our Cancer Screening Day, please call to schedule your 15-minute appointment at (833) 255-0431.